Featured New InvestigatorBronchiolitis obliterans in lung transplantation: the good, the bad, and the future
Section snippets
Current Models
An understanding of the current knowledge in lung transplant research requires a brief introduction to the models used to study OB. In the early 1980s, Marck et al24, 25, 26 demonstrated that lung transplantation in rats was technically feasible and used imaging modalities to assess allograft function. Despite its early successes, the rat model has subsequently yielded mixed results. Yasufuku et al27 have successfully used the rat model to study the pathogenesis of OB and have recently
Alloimmunity
The primary basis for rejection of solid organs is host recognition of non-self-donor antigens or the alloimmune response. The immune response to alloantigens is primarily initiated by a T-cell response, which may then promote a B-cell response that leads to alloantibody production. After transplantation, the T-cell receptor (TCR) on host T cells recognizes its cognate peptide major histocompatibility complex (MHC) present on donor cells. Why humans have evolved to have alloreactive T and B
Innate Immunity: Toll-Like Receptor (TLR) Ligands
A challenge for improving lung transplantation outcomes is to dissect the unique mechanisms by which the lung, unlike other solid organs, may respond to stressors, such as I/R injury, infection, and environmental insults. The normal lung has dendritic cells, macrophages, epithelium, and endothelium, which all contribute to its defense against the environment and mediate the innate immune response. How these cells respond to stimuli impacts the adaptive immune response of T and B cells. The
Innate Immunity: Dendritic Cells
The major APC type that links the innate immune response in the lung to activation of the alloimmune response is the dendritic cell (DC).62, 63 DCs after transplantation migrate from the donor to the recipient's lymph nodes and directly induce the alloimmune response (Fig 1). Studies have found that depletion of DCs significantly abrogates acute allograft rejection in both animal models and human kidney transplant patients.63 Because the mucosal surface of the lung is estimated to have a
Innate Immunity: Macrophages and Other Innate Cells
Although DCs are the likely APCs responsible for initiating the alloimmune response, other innate cell types in the lung clearly modify the adaptive immune response. Macrophages, neutrophils, mast cells, and natural killer (NK) cells have been implicated in transplantation. Macrophages play a role in lung homeostasis and pathogen defense and have been shown to be a source of growth factors thought to mediate the fibroproliferation characteristic of OB in humans.71 Depletion of macrophages in a
Adaptive Immune Response
Studies in humans with BOS have consistently implicated persistent alloimmunity in the pathogenesis of OB. Although the association of MHC class II expression with the development of OB has long been recognized,47 more recently, direct evidence of persistent alloimmune humoral and cellular responses has been found. Humans with antidonor HLA antibodies have been found to be more likely to develop BOS79, 80; as discussed above, anti–donor-specific indirect T-cell responses have also been
Structural Cells
Epithelium. Although the alloimmune response clearly plays a role in the pathogenesis leading to OB, the epithelium has long been thought to contribute to the fibrotic response in the lung. Numerous studies have implicated epithelial cells as both a major target of the immune response and as a causative agent in the creation of OB.93, 94, 95 It is hypothesized that severe damage to bronchiolar epithelium may lead to excessive proliferation of granulation tissue and destructive fibrous scarring
Future Directions
New models are constantly being developed to determine the mechanisms of OB more accurately. The ideal model for studying lung alloreactivity would be one that is not technically prohibitive and that closely resembles both the natural pulmonary physiology, as well as the pathophysiology of lung transplantation rejection both acute and chronic. Currently, none of the available models fulfill these criteria. The limitations of the current models have provided an incentive to investigators to
Summary
The lung is a complex organ involved in mucosal defense and gas exchange in which the immune system has evolved to protect both barriers. The response to chronic alloimmune mediated and acute I/R injury including PGD, infectious, and environmental insults and their effects on the adaptive immune response are only beginning to be defined (Fig 2). The future of lung transplantation depends on dissecting the deleterious immune response to these insults and on determining the mechanisms promoting a
References (124)
- et al.
Registry of the international society for heart and lung transplantation: twenty-fifth official adult lung and heart/lung transplantation report—2008
J Heart Lung Transplant
(2008) - et al.
Intermediate-term results after en bloc double-lung transplantation with bronchial arterial revascularization. Bordeaux Lung and Heart-Lung Transplant Group
J Thorac Cardiovasc Surg
(1996) - et al.
Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome
Am J Transplant
(2008) - et al.
Report of the ISHLT Working group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation
J Heart Lung Transplant
(2005) - et al.
Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation
Ann Thorac Surg
(2000) - et al.
Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants
Am J Transplant
(2006) - et al.
Lung transplantation in the rat: I. Technique and survival
Ann Thorac Surg
(1982) - et al.
Lung transplantation in the rat: II. lung perfusion scintigraphy in normal and left lung-transplanted rats
Ann Thorac Surg
(1982) - et al.
Lung transplantation in the rat. III. Functional studies in iso- and allografts
J Surg Res
(1983) - et al.
Lung transplantation in the Fischer 344–>Wistar Kyoto rat strain combination is not suitable to study bronchiolitis obliterans
J Heart Lung Transplant
(2007)
Obliterative bronchiolitis develops in miniature swine transplanted across a minor histocompatibility barrier
Transplant Proc
A novel model for post-transplant obliterative airway disease reveals angiogenesis from the pulmonary circulation
Am J Transplant
Allograft airway fibrosis in the pulmonary milieu: a disorder of tissue remodeling
Am J Transplant
A mouse model of orthotopic vascularized aerated lung transplantation
Am J Transplant
Pathways of allorecognition: implications for transplantation tolerance
Transpl Immunol
The importance of the indirect pathway of allorecognition in clinical transplantation
Curr Opin Immunol
A role for indirect allorecognition in lung transplant recipients with obliterative bronchiolitis
Am J Transplant
Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome
Am J Transplant
Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance
Am J Transplant
Lung immunogenicity, rejection, and obliterative bronchiolitis
Chest
Pathogen recognition and innate immunity
Cell
The role of hyaluronan degradation products as innate alloimmune agonists
Am J Transplant
TLR engagement prevents transplantation tolerance
Am J Transplant
Toll-like receptor 4 mediates lung ischemia-reperfusion injury
Ann Thorac Surg
Differentiation and function of Th17 T cells
Curr Opin Immunol
Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation
Ann Thorac Surg
Role of airway epithelial injury in murine orthotopic tracheal allograft rejection
Ann Thorac Surg
Risk factors for bronchiolitis obliterans: a systematic review of recent publications
J Heart Lung Transplant
Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation
J Heart Lung Transplant
T helper cell effector fates—who, how and where?
Curr Opin Immunol
Further evidence that NK cells may contribute to the development of cardiac allograft vasculopathy
Transplant Proc
Natural killer cells in peripheral blood and lung tissue are associated with chronic rejection after lung transplantation
J Heart Lung Transplant
Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance
Transpl Immunol
Immunological link between primary graft dysfunction and chronic lung allograft rejection
Ann Thorac Surg
The biological functions of T helper 17 cell effector cytokines in inflammation
Immunity
Immune therapies of autoimmune diseases: are we approaching a real cure?
Curr Opin Immunol
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome
Hum Immunol
Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease
Am J Transplant
Airway epithelial cell damage mediated by antigen-specific T cells: implications in lung allograft rejection
Hum Immunol
Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways?
Ann Thorac Surg
Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation
J Heart Lung Transplant
Pathologic pulmonary alterations in long-term human heart-lung transplantation
Hum Pathol
Functions of a transplanted kidney
Science
The reversal of rejection in human renal homografts with subsequent development of homograft tolerance
Surg Gynecol Obstet
Mechanisms of airway obliteration after lung transplantation
Proc Am Thorac Soc
Lung transplantation: opportunities for research and clinical advancement
Am J Respir Crit Care Med
Human and murine obliterative bronchiolitis in transplant
Proc Am Thorac Soc
Analysis of risk factors for the development of bronchiolitis obliterans syndrome
Am J Respir Crit Care Med
Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation
Am J Respir Crit Care Med
Cited by (46)
Nonneoplastic pathology of the large and small airways
2022, Practical Pulmonary Pathology: A Diagnostic ApproachCommentary: It's time for exosomes to get the limelight in lung transplant
2021, Journal of Thoracic and Cardiovascular SurgeryPotential role of exosome-based allorecognition pathways involved in lung transplant rejection
2021, Journal of Thoracic and Cardiovascular SurgeryCommentary: Curiouser and curiouser—The role of exosomes in transplant rejection
2021, Journal of Thoracic and Cardiovascular SurgeryIntractable diffuse pulmonary diseases: Manual for diagnosis and treatment
2021, Respiratory InvestigationCitation Excerpt :All information on case analysis in detail is available to a book, titled Intractable diffuse pulmonary diseases: manual for the diagnosis and treatment by the Japanese Respiratory Society, 2017, written in Japanese (ISBN 978-4-524-25118-6) [30]. The relatively known diseases that can cause bronchiolitis obliterans are listed in Table 4 [25,27–29,31–46]. The mechanisms for the pathogenesis of the development of bronchiolitis obliterans might be varied.
Nonneoplastic Diseases of the Trachea and Bronchi
2018, Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series
Supported by Grant K08 AI 059105 from the National Institute of Health and the Louis Block Fund.
- ∗
Rebecca A. Shilling, MD, is Assistant Professor in the Department of Medicine, Section of Pulmonary and Critical at the University of Chicago. Her article is based on a presentation given at the Combined Annual Meeting of the Central Society for Clinical Research and Midwestern Section American Federation for Medical Research held in Chicago, Ill, April 2008.